New Industry Research Shows Record 11,458 Hospitals and Surgical Centers in 18 Countries Used Reprocessed Devices to Reduce Costs, Emissions Last Year [Washington, DC / Berlin, Germany — 11 May 2026] The Association of Medical Device Reprocessors (AMDR) and its members released the results of its 2025 member survey. Among the key findings (all data

[Washington, D.C. — March 26, 2026] — Medline Renewal, an AMDR member, completed a voluntary recall for several of its reprocessed electrophysiology catheters and an electrosurgical product. Medline Renewal informed customers promptly to pull these products off the shelves in July 2025 with updated lots recalled in December 2025. Through this process, the recalled devices were

[Washington, D.C. — March 8, 2026] — Patient safety is the medical device reprocessing industry’s highest priority.  Regulated by the U.S. Food and Drug Administration (FDA), single use device reprocessors are subject to stringent regulation and are required to show that a reprocessed device will remain substantially equivalent to the original device, post-reprocessing. All AMDR

Yesterday Court Issued Final Injunction After Jury Finds that Biosense Webster’s Unlawful, Anti-Competitive Practices Forced Hospitals to Purchase More Costly, Wasteful Products [Washington, D.C. — August 28, 2025] — The Association of Medical Device Reprocessors (AMDR) announced that Judge James Selna of the U.S. District Court for the Central District of California has issued a